Commentary on "Transdermal DMPS".
作者信息
McKay Charles
出版信息
J Med Toxicol. 2013 Mar;9(1):1-3. doi: 10.1007/s13181-012-0277-4.
Abstract
摘要
相似文献
1
Commentary on "Transdermal DMPS".关于“经皮二巯基丙磺酸钠”的述评
J Med Toxicol. 2013 Mar;9(1):1-3. doi: 10.1007/s13181-012-0277-4.
2
Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).经皮二巯丁二酸（TD-DMPS）经皮给药后血浆和尿液中二巯丁二磺酸浓度。
J Med Toxicol. 2013 Mar;9(1):9-15. doi: 10.1007/s13181-012-0272-9.
3
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans.
J Pharmacol Exp Ther. 1991 Nov;259(2):808-14.
4
Interaction of the metal chelator DMPS with OAT1 and OAT3 in intact isolated rabbit renal proximal tubules.金属螯合剂二巯基丙磺酸钠（DMPS）与完整分离的兔肾近端小管中OAT1和OAT3的相互作用。
Am J Physiol Renal Physiol. 2004 Jan;286(1):F68-76. doi: 10.1152/ajprenal.00075.2003. Epub 2003 Sep 16.
5
2,3-Dimercapto-1-propanesulphonate in heavy metal poisoning.2,3-二巯基-1-丙磺酸盐用于重金属中毒治疗
Med Toxicol Adverse Drug Exp. 1987 Sep-Oct;2(5):317-23. doi: 10.1007/BF03259951.
6
Determination and metabolism of dithiol chelating agents. IV. Urinary excretion of meso-2,3-dimercaptosuccinic acid and mercaptosuccinic acid in rabbits given meso-2,3-dimercaptosuccinic acid.
Biochem Pharmacol. 1989 Apr 1;38(7):1147-54. doi: 10.1016/0006-2952(89)90261-x.
7
8
9
10
[The mercury exposure of the population. III. Mercury mobilisation by DMPS (Dimaval) in subjects with and without amalgam fillings].[人群的汞暴露。III. 二巯丙磺钠（二巯丙磺钠注射液）对有或无汞合金填充物受试者汞的动员作用]
Zentralbl Hyg Umweltmed. 1992 Feb;192(5):447-54.
本文引用的文献
1
Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).经皮二巯丁二酸（TD-DMPS）经皮给药后血浆和尿液中二巯丁二磺酸浓度。
J Med Toxicol. 2013 Mar;9(1):9-15. doi: 10.1007/s13181-012-0272-9.
2
American College of Medical Toxicology position statement on post-chelator challenge urinary metal testing.美国医学毒理学学院关于螯合剂激发后尿金属检测的立场声明。
J Med Toxicol. 2010 Mar;6(1):74-5. doi: 10.1007/s13181-010-0039-0.
3
ACMT position statement: the Iom report on thimerosal and autism.美国毒理学会立场声明：医学研究所在硫柳汞与自闭症方面的报告。
J Med Toxicol. 2006 Dec;2(4):170-1. doi: 10.1007/BF03161188.
4
A case series of children with apparent mercury toxic encephalopathies manifesting with clinical symptoms of regressive autistic disorders.
J Toxicol Environ Health A. 2007 May 15;70(10):837-51. doi: 10.1080/15287390701212141.
5
Biopharmaceutics and pharmacokinetics in drug research.药物研究中的生物药剂学与药代动力学
Int J Pharm. 2000 May 25;201(2):131-50. doi: 10.1016/s0378-5173(00)00344-6.
6
Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
Environ Health Perspect. 1998 Aug;106 Suppl 4(Suppl 4):1017-25. doi: 10.1289/ehp.98106s41017.
Zotero 插件